At 15, Reyna is a two-year pancreatic cancer survivor. She’s taking steps to end the disease at PanCAN PurpleStride 2026 and wants you to join her!
PanCAN Chief Scientific & Medical Officer Dr. Anna Berkenblit highlights the latest advances in precision medicine ...
Optune Pax® with the chemotherapy combination of gemcitabine and nab-paclitaxel is the first treatment to be FDA approved in nearly 30 years for locally advanced pancreatic cancer.
Join PanCAN on Thursday, March 26, at 11 a.m. PT / 2 p.m. ET, for our Nutrition Month webinar. Our panel of special guests will talk about common nutritional challenges as well as leading-edge ...
It’s dark. It’s cold. It’s winter. For people living in many parts of the U.S., this trifecta may affect a person’s mood in different ways, including for some the onset of seasonal affective disorder ...
Editor’s Note: Michigan PurpleStride Chair Renee Clearman spoke with Community Engagement Senior Specialist Paula Mukherjee about her passion for PanCAN’s mission and excitement for PanCAN ...
PanCAN Patient Services is the place to contact when facing pancreatic cancer. Our highly trained and compassionate Case Managers provide free, personal one-to-one support and information about the ...
The National Comprehensive Cancer Network ® is a group of leading cancer centers focused on improving cancer care for patients. The organization creates guidelines aimed to help healthcare ...
American Cancer Society’s Cancer Facts & Figures 2023, released today, reports that the five-year survival rate for pancreatic cancer is now 12%, an increase of one percentage point from last year.
July 1, 2021 marks 30 years since the beloved actor, writer and director Michael Landon – best known for playing Little Joe Cartwright on “Bonanza,” Charles (Pa) Ingalls on “Little House on the ...
For the third year in the row, the five-year survival rate for pancreatic cancer has increased one percentage point, according to the American Cancer Society’s Cancer Facts & Figures 2024 Report ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results